Nureca Ltd - 543264 - Closure of Trading Window
Trading Window for dealing in the equity shares of the Company will remain closed from December 24, 2021 (Friday) till the completion of 48 hours after the declaration of un-audited Financial Results of the Company for the third quarter and nine months ending on December 31, 2021. Nureca Ltd - 543264 - Related Party Transactions For The Half-Year Ended 30Th September 2021
Related Party Transactions for the half-year ended 30th September 2021 Nureca Ltd - 543264 - Announcement under Regulation 30 (LODR)-Change in Registered Office Address
Intimation of change of Registered Office of the Company Nureca Ltd - 543264 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Publication of Financial Results of the Company for the second Quarter and half year ended September 30, 2021, which have been published in the following newspapers: 1. Business Standard (English- All Editions) 2.Nav Shakti (Marathi) Nureca Ltd - 543264 - ''Disclosure Under Regulation 30 (5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Details of Key Managerial Personnel (KMP's) of the Company which are authorized to determine materiality of an event or information and making disclosures to stock exchange(s) Q2FY22 Quarterly Result Announced for Nureca Ltd.
Highlights: GMV for the H1F22 at Rs. 2,285mn as compared to Rs. 1,826mn in H1FY21, an increase of 30% Operating Revenue was Rs. 1,664mn in H1FY22 as compared to Rs. 1,221mn in H1FY21, an increase of 36% Our core products i.e. Bp monitor and Glucometer, both continue to outperform the market with revenue from both products more than 60% in H1FY22 compared to same period last year EBITDA was Rs. 574mn as compared to Rs. 500mn in H1FY21, an increase of 15% PAT stood at Rs. 416mn as compared to Rs. 362mn in H1FY21, a growth of 15% Strong balance sheet with Cash and Cash equivalents of Rs. 127 cr. as of September 20721 Result PDF Nureca Ltd - 543264 - Statement Of Deviation & Variation
Statement of Deviation & Variation for quarter ended September 2021 Nureca Ltd - 543264 - Appointment of Company Secretary and Compliance Officer
Outcome of Board Meeting - Appointment of Company Secretary & Compliance officer Nureca Ltd - 543264 - Financial Results For The Quarter And Half Year Ended September 2021
Outcome of Board Meeting under Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
